OTC Markets OTCPK - Delayed Quote USD

Craneware plc (CRWRF)

24.25
0.00
(0.00%)
As of May 8 at 4:00:00 PM EDT. Market Open.
Loading Chart for CRWRF
  • Previous Close 24.25
  • Open 24.25
  • Bid 21.32 x 40000
  • Ask 26.32 x 40000
  • Day's Range 24.25 - 24.25
  • 52 Week Range 23.86 - 30.00
  • Volume 290
  • Avg. Volume 12
  • Market Cap (intraday) 858.688M
  • Beta (5Y Monthly) 0.28
  • PE Ratio (TTM) 57.74
  • EPS (TTM) 0.42
  • Earnings Date Mar 11, 2025
  • Forward Dividend & Yield 0.38 (1.58%)
  • Ex-Dividend Date Mar 20, 2025
  • 1y Target Est --

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity requirements; Trisus Claims Informatics, a retrospective charge capture analytical application; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit solution for government and commercial payors. It also offers Trisus Decision Support; Trisus Labor Productivity, which enables healthcare providers to manage, analyze, and plan the deployment of workforce; Trisus Medication Analytic solutions that prioritize, diagnose, and resolve issues in medication systems; and Trisus supplies assistant solutions which supplies charged data. In addition, the company provides Sentrex, a SaaS-based solution that helps covered entities expand medication access; Sentinel, that tracks all drug activity; Referral Verification System; and Central Pharmacy Distribution, a centralized purchasing application. Further, it offers professional, pharmacy professional, and appeal services. Additionally, the company provides The Academy, an interactive learning center for user training; Trisus Pricing Integrity Suite; Trisus Business of Pharmacy Suite, which offers solutions centered on each link in the medication revenue cycle; Trisus Value-based Margin and Productivity Suite; and Trisus Data Integrity Suite, which creates a proactive workflow that aligns data between operating units, the supply chain and revenue cycle. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.

www.thecranewaregroup.com

747

Full Time Employees

June 30

Fiscal Year Ends

Recent News: CRWRF

View More

Performance Overview: CRWRF

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

CRWRF
12.77%
FTSE 100 (^FTSE)
4.67%

1-Year Return

CRWRF
12.96%
FTSE 100 (^FTSE)
2.07%

3-Year Return

CRWRF
20.48%
FTSE 100 (^FTSE)
18.54%

5-Year Return

CRWRF
2.71%
FTSE 100 (^FTSE)
44.12%

Compare To: CRWRF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CRWRF

View More

Valuation Measures

Annual
As of 5/8/2025
  • Market Cap

    851.84M

  • Enterprise Value

    815.57M

  • Trailing P/E

    57.06

  • Forward P/E

    20.75

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.32

  • Price/Book (mrq)

    2.61

  • Enterprise Value/Revenue

    4.12

  • Enterprise Value/EBITDA

    14.17

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.51%

  • Return on Assets (ttm)

    2.52%

  • Return on Equity (ttm)

    4.55%

  • Revenue (ttm)

    198.1M

  • Net Income Avi to Common (ttm)

    14.88M

  • Diluted EPS (ttm)

    0.42

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    72.16M

  • Total Debt/Equity (mrq)

    10.90%

  • Levered Free Cash Flow (ttm)

    59.59M

Research Analysis: CRWRF

View More

Company Insights: CRWRF

Research Reports: CRWRF

View More

People Also Watch